Altria Group, Inc. Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount
Altria Group, Inc. (MO) reported Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-27.
Discontinued › Expense Statement › Operating Expenses
us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount · last filed 2023-02-27
- Altria Group, Inc. equity securities without readily determinable fair value, impairment loss, annual amount for the quarter ending 2021-12-31 was $0.00.
- Altria Group, Inc. equity securities without readily determinable fair value, impairment loss, annual amount for the quarter ending 2021-09-30 was $0.00, a 100.00% decline year-over-year.
- Altria Group, Inc. equity securities without readily determinable fair value, impairment loss, annual amount for the quarter ending 2020-12-31 was $0.00, a 100.00% decline year-over-year.
- Altria Group, Inc. equity securities without readily determinable fair value, impairment loss, annual amount for the quarter ending 2020-09-30 was $2.60B, a 42.22% decline year-over-year.
- Altria Group, Inc. equity securities without readily determinable fair value, impairment loss, annual amount for fiscal 2022 was $0.00.
- Altria Group, Inc. equity securities without readily determinable fair value, impairment loss, annual amount for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- Altria Group, Inc. equity securities without readily determinable fair value, impairment loss, annual amount for fiscal 2020 was $2.60B, a 69.77% decline from fiscal 2019.
- Altria Group, Inc. equity securities without readily determinable fair value, impairment loss, annual amount for fiscal 2019 was $8.60B.
| Period end | Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 3 month | Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 6 month | Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 9 month | Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-02-27 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $0.00 derived: sum of 2 quarters · filed 2023-02-27 | $0.00 10-K · filed 2023-02-27 | |
| 2021-09-30 | $0.00 10-Q · filed 2021-10-28 | $0.00 10-Q · filed 2021-10-28 | ||
| 2020-12-31 | $0.00 10-K · filed 2021-02-26 | $2.60B derived: sum of 2 quarters · filed 2021-10-28 | $2.60B derived: sum of 3 quarters · filed 2021-10-28 | $2.60B 10-K · filed 2023-02-27 |
| 2020-09-30 | $2.60B 10-Q · filed 2021-10-28 | $2.60B derived: sum of 2 quarters · filed 2021-10-28 | $2.60B 10-Q · filed 2021-10-28 | $6.70B derived: sum of 4 quarters · filed 2021-10-28 |
| 2020-06-30 | $0.00 10-K · filed 2021-02-26 | $0.00 derived: sum of 2 quarters · filed 2021-02-26 | $4.10B derived: sum of 3 quarters · filed 2021-02-26 | $8.60B derived: sum of 4 quarters · filed 2021-02-26 |
| 2020-03-31 | $0.00 10-K · filed 2021-02-26 | $4.10B derived: sum of 2 quarters · filed 2021-02-26 | $8.60B derived: sum of 3 quarters · filed 2021-02-26 | $8.60B derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-12-31 | $4.10B 10-K · filed 2021-02-26 | $8.60B derived: sum of 2 quarters · filed 2021-02-26 | $8.60B derived: sum of 3 quarters · filed 2021-02-26 | $8.60B 10-K · filed 2022-02-25 |
| 2019-09-30 | $4.50B 10-K · filed 2021-02-26 | $4.50B derived: sum of 2 quarters · filed 2021-02-26 | $4.50B 10-Q · filed 2020-10-30 | $4.50B derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | $0.00 10-K · filed 2021-02-26 | $0.00 derived: sum of 2 quarters · filed 2021-02-26 | $0.00 derived: sum of 3 quarters · filed 2021-02-26 | $0.00 derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | $0.00 10-K · filed 2021-02-26 | $0.00 derived: sum of 2 quarters · filed 2021-02-26 | $0.00 derived: sum of 3 quarters · filed 2021-02-26 | |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $0.00 derived: sum of 2 quarters · filed 2021-02-26 | $0.00 10-K · filed 2021-02-26 | |
| 2018-09-30 | $0.00 10-Q · filed 2019-10-31 | $0.00 10-Q · filed 2019-10-31 | ||
| 2017-12-31 | $0.00 10-K · filed 2020-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ispire Technology Inc. (ISPR) | United States | $0.075B | -1.93 |
| 22nd Century Group, Inc. (XXII) | United States | $0.001B | -0.53 |
| Philip Morris International Inc. (PM) | United States | $298.506B | 25.92 |